loadpatents
name:-0.011563062667847
name:-0.003734827041626
name:-0.0032649040222168
Larsen; Glenn Patent Filings

Larsen; Glenn

Patent Applications and Registrations

Patent applications and USPTO patent grants for Larsen; Glenn.The latest application filed is for "method of treating a localized fibrotic disorder using a tnf receptor 2 antagonist".

Company Profile
3.4.12
  • Larsen; Glenn - Sudbury MA
  • Larsen; Glenn - Norton MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method of treating a localized fibrotic disorder using an IL-33 antagonist
Grant 11,400,154 - Larsen , et al. August 2, 2
2022-08-02
Method Of Treating A Localized Fibrotic Disorder Using A Tnf Receptor 2 Antagonist
App 20210386855 - Larsen; Glenn ;   et al.
2021-12-16
Method Of Treating A Localized Fibrotic Disorder Using An Il-33 Antagonist
App 20200338193 - Larsen; Glenn ;   et al.
2020-10-29
Method of treating a localized fibrotic disorder using an IL-33 antagonist
Grant 10,500,273 - Larsen , et al. Dec
2019-12-10
Method Of Treating A Localized Fibrotic Disorder Using A Tnf Receptor 2 Antagonist
App 20180036404 - Larsen; Glenn ;   et al.
2018-02-08
Method Of Treating A Localized Fibrotic Disorder Using An Il-33 Antagonist
App 20180030130 - Larsen; Glenn ;   et al.
2018-02-01
Method Of Treating Fibroproliferative Disorders Including Dupuytren's Disease With One Or More Specific Human Matrix Metalloproteinase And A Tnf Antagonist
App 20160158325 - Larsen; Glenn
2016-06-09
Generating a Savings Plan
App 20090192947 - Kenigsberg; Matthew B. ;   et al.
2009-07-30
Methods and compositions for modulating interleukin-21 receptor activity
Grant 7,198,789 - Carter , et al. April 3, 2
2007-04-03
Compositions and methods for treating rage-associated disorders
App 20060140933 - Pittman; Debra D. ;   et al.
2006-06-29
Methods of promoting cardiac cell proliferation
App 20050261189 - Larsen, Glenn ;   et al.
2005-11-24
Methods and compositions for modulating interleukin-21 receptor activity
App 20030108549 - Carter, Laura ;   et al.
2003-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed